Labshake search

Citations for Selleck Chemicals :

1 - 3 of 3 citations for "S2853" since 2019

Citations are collected from bioRxiv only, the total number of publications could be much larger.

A Cryptic K48 Ubiquitin Chain Binding Site on UCH37 is Required for its Role in Proteasomal Degradation

Jiale Du, et al., bioRxiv - Biochemistry 2021

Quote: Carfilzomib (PR-171) (Selleck Chemicals, Cat. # S2853)

Product cited:

Carfilzomib (PR-171)

Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells,...

Cat# S2853, SKU# S2853-10mM/1mL, 10mM/1mL, $97.00 Ask
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis

Kranthi Kumar Chougoni, et al., bioRxiv - Cancer Biology 2024

Quote: ... carfilzomib (Selleck Chemicals, S2853, Houston, TX, USA), navitoclax (MedChemExpress HY-10087) ...

Product cited:

Carfilzomib (PR-171)

Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells,...

Cat# S2853, SKU# S2853-10mM/1mL, 10mM/1mL, $97.00 Ask
Deubiquitinase UCHL1 Maintains Protein Homeostasis through PSMA7-APEH-Proteasome Axis in High-Grade Serous Ovarian Carcinoma

Apoorva Tangri, et al., bioRxiv - Cancer Biology 2020

Quote: ... Cells were treated with Carfilzomib (cat# S2853, Selleck Chemicals) and 5-Aza-2′-deoxycytidine (Sigma-Aldrich ...

Product cited:

Carfilzomib (PR-171)

Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells,...

Cat# S2853, SKU# S2853-10mM/1mL, 10mM/1mL, $97.00 Ask

Feedback